Shanghai Sine Wanxiang Pharmaceutical Co., Ltd. (hereinafter as "Sine Wanxiang") is a state-owned pharmaceutical company, which belongs to Prescription Division of Shanghai Pharmaceutical (Group) Corp. Our predecessor is Shanghai Yanan Pharmaceutical Factory which has over a 100-year history. By the assets reorganization and name change, Sine Wanxiang was finally established in the year of 1999.

Sine Wanxiang owns two production sites with over 200 kinds of products, involving in tablets, hard capsules, soft gel capsules, granules and APIs. One production site is in Qingpu district, occupying a plant area of 20,869 square meters and mainly producing tablets, hard capsules, granules and APIs. The yearly manufacturing capacity is 2 billion of tablets, 0.4 billion of capsules and 25 thousand kilograms of granules; The other production site is in Jinshan district, occupying a plant area of 18048 square meters. Through another assets reorganization and name change in the year of 2004, the production site in Jinshan district has changed its name to "Shanghai Sine Yanan Pharmaceutical Co., Ltd." which is mainly producing soft gel capsules with the yearly manufacturing capacity of 0.4 billion capsules. The production sites both in Qingpu district and in Jinshan district have boasted the GMP certificate issued by SFDA of China and MCC of South Africa.

The main products in Sine Wanxiang are divided into several series, such as: Cardiovascular series; Gastrointestinal series; Antibacterial series; Anti-tuberculosis series;and Others. E.g. acne treatment drugs; anti-osteoporosis agents; antidepressant drug; azasetron hydrochloride (API, antemetic).

Our competitive dosage forms are soft gel capsule and sustained-release preparation. Since 2003, we have been exporting our products to South Africa, Thailand, and some other Southeast Asian countries. In recent years, we also actively accept OEM both domestic and overseas. In order to further develop our overseas businesses, company senior leaders have decided to invest a brand new soft gel capsule workshop that are expected to meet the requirements of international advanced level and to pass the FDA audit. This new workshop will be completed at the end of 2008 and the manufacturing capacity can achieve 1.0 billion capsules per year. We believe that the international trade of our company will reach a new peak by then.

Sine Wanxiang insists on regarding Good Faith as the core of corporation culture and will go in for building up a first-class enterprise under the conduct of a policy of "Innovation initials the value, devotion makes the best".

Please feel free to contact us for more information.